|Articles|October 20, 2020
- Ophthalmology Times: September 15, 2020
- Volume 45
- Issue 15
Options give 1-2 punch to metastatic uveal melanoma
Author(s)Lynda Charters
Combining RAF/MEK signaling pathway inhibitor with FAK inhibitor raises bar
Advertisement
This article was reviewed by Justine S. Paradis, PhD
The results of a preclinical study indicate there is hope for an effective treatment for the GNAQ-driven metastatic uveal melanoma, an aggressive form of the disease.